CD4 and neoplasm: PD-1 can also be expressed on tumor-infiltrating lymphocytes (TILs), while tumor cells may express PD-L1 at varying levels, contributing to the inhibition of CD4+ and CD8+ T-cell activation and the apoptosis of antigen-specific T-cell clones [43,44].